THINK UTRECHT: Innovaties van nu, kankerzorg van morgen

Think Utrecht: Innovaties van nu, kankerzorg van morgen

Josef Vormoor appointed as Professor of Hematological Malignancies in Children

Margreet Ausems appointed as professor of Clinical Oncogenetics at UMC Utrecht

Unraveling the genetic evolution of individual tumor cells

A technical breakthrough: Snippert and colleagues report the first detailed insights into the pace and patterns by which genetic alterations are generated by tumors. This may help predict whether benign colon polyps can eventually turn malignant. See the publication here: https://go.nature.com/2UfgAls

DENSE research wins Science and Innovation Prize 2021

Breast cancer in women with dense mammary gland tissue is better detectable with an MRI

'Live' measurements of cell signals show need for combination therapy in colorectal cancer

'Live' metingen van celsignalen tonen noodzaak van combinatietherapie bij dikkedarmkanker

Lex Eggermont appointed as professor of Immunotherapy at UMC Utrecht

Scientific director of the Princess Máxima Center, Lex Eggermont, has been appointed professor of Clinical and Translational Immunotherapy at the Faculty of Medicine of Utrecht University.

OVERVIEW 2020 Strategic Program Cancer

Consortium maakt multidisciplinair internationaal onderzoek naar lobulair borstkanker mogelijk

Onderzoekers van het UMC Utrecht en KU Leuven hebben met steun van een EU COST beurs een internationaal consortium opgericht ter ondersteuning van onderzoek naar Invasief Lobulair Borstkanker (ILC). Aan het project nemen onderzoekers uit 21 landen deel. Het Europese Lobulair Borstkanker Consortium (ELBCC) is een initiatief van wetenschappers Patrick Derksen van het UMC Utrecht en Christine Desmedt van de KU Leuven.

Consortium enables research lobular breast cancer

Researchers from UMC Utrecht and KU Leuven have set up an international consortium with the support of an EU COST grant for research into Invasive Lobular Breast Cancer (ILC). Researchers from 21 countries are participating in the project. The European Lobular Breast Cancer Consortium (ELBCC) is an initiative of scientists Patrick Derksen from the UMC Utrecht and Christine Desmedt from the KU Leuven.